JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Publication history |
Reprints |
Permissions |
Cite this article as |
Share |
YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
MINERVA OPINION EDITORIAL Free access
Minerva Urology and Nephrology 2021 August;73(4):421-3
DOI: 10.23736/S2724-6051.21.04525-0
Copyright © 2021 EDIZIONI MINERVA MEDICA
language: English
Senescence in prostate cancer: is there sufficient evidence to move forward?
Valerie CARPENTER 1, 2 ✉, Riccardo AUTORINO 3, David A. GEWIRTZ 1, 2
1 School of Medicine, Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA; 2 Massey Cancer Center, Richmond, VA, USA; 3 Division of Urology, Department of Surgery, VCU Health, Richmond, VA, USA